Abbott Laboratories (ABT) Monday announced FDA clearance for two new over-the-counter continuous glucose monitoring systems - Lingo and Libre Rio.
Abbott said, these two systems are based on its FreeStyle Libre continuous glucose monitoring technology.
Lingo is a consumer biowearable and is designed for general consumers who are looking to improve their overall health and wellness, while Libre Rio is designed for adults with Type 2 diabetes, who do not use insulin and manage diabetes through lifestyle modifications.
The Lingo system combines a biosensor that is worn on the upper arm for 14 days. Libre Rio is the first over-the-counter continuous glucose monitoring system with a measurement range of 40-400 mg/dL.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.